Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis

PURPOSE: Intravitreal (IVT) injections of the anti-vascular endothelial growth factor (VEGF) agents aflibercept, bevacizumab, and ranibizumab are commonly prescribed to treat neovascular age-related macular degeneration (nAMD). Studies comparing inflammation rates in large populations of patients re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiss, Szilárd, Dugel, Pravin U, Khanani, Arshad M, Broder, Michael S, Chang, Eunice, Sun, Gordon H, Turpcu, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124467/
https://www.ncbi.nlm.nih.gov/pubmed/30214147
http://dx.doi.org/10.2147/OPTH.S169143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124467/
https://www.ncbi.nlm.nih.gov/pubmed/30214147
http://dx.doi.org/10.2147/OPTH.S169143

Ejemplares similares